Goldman Sachs
-
Mainland-based healthcare sector issuers SciClone Phamaceuticals (Holdings), New Horizon Health and Joinn Laboratories (China) kicked off pre-deal investor education for their Hong Kong IPOs on Monday. -
Europe’s convertible bond market has got off to a relatively slow start to the year, with €1.6bn of issuance in January, according to Dealogic data. However, the asset class remains popular with investors looking to gain equity upside but mitigate against valuation risk.
-
Ukraine is facing delays in securing funding disbursements from the IMF, as questions around the authenticity of its anti-corruption drive cloud discussions between the country and the Fund. That may push Ukraine to tap the bond markets again, which last year welcomed it a number of times.
-
-
-
Austria, Greece and Iceland all received huge order books for their first syndicated bonds of the year, coming hot on the heels of a European Union jumbo dual-tranche sale earlier in the week.
-
The European Union continued where it left off last year as it returned to the bond market this week with another jumbo deal that attracted a huge order book for the first deal of the year under its Support to Mitigate Unemployment Risks in an Emergency (SURE) funding programme.
-
-
The Republic of Slovenia sold its longest ever bond issue on Wednesday, just three weeks after it sold a €2bn deal. The bid for duration was evident as investors piled in with more than €4bn of orders.
-
IDB Invest, the private sector arm of the Inter-American Development Bank, is preparing to issue the first bond under its new sustainability debt framework.
-
The IPO of Dr Martens, the UK bootmaker, shut on Thursday, two days earlier than planned after the company attracted heavy demand in its first few days of bookbuilding.
